[Combined treatment and prognostic factors for stage III and IV endometrial carcinoma].

Zhonghua fu chan ke za zhi

Volumn 43, Issue 7, 2008, Pages 523-527

  Ren, Yu lan ^a   Wang, Hua ying ^b   Shi, Da ren ^b   Yang, Wen tao ^b   Sun, Zhi ^b   Chen, Yun ^b  

^a FUDAN UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; ENDOMETRIUM TUMOR; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; LYMPH NODE; LYMPHADENECTOMY; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; LYMPH NODES; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80053305989     PISSN: 0529567X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)